These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9034638)

  • 1. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events.
    Grimm W; Steder U; Menz V; Hoffmann J; Maisch B
    Clin Cardiol; 1997 Feb; 20(2):107-10. PubMed ID: 9034638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome.
    Meierhenrich R; Helguera ME; Kidwell GA; Tebbe U
    Int J Cardiol; 1997 Aug; 60(3):289-94. PubMed ID: 9261640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy.
    Grimm W; Steder U; Menz V; Hoffman J; Maisch B
    Am J Cardiol; 1996 Aug; 78(4):458-61. PubMed ID: 8752193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone.
    Aiba T; Shimizu W; Inagaki M; Satomi K; Taguchi A; Kurita T; Suyama K; Aihara N; Sunagawa K; Kamakura S
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):901-9. PubMed ID: 15271008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia.
    Kotake Y; Kurita T; Akaiwa Y; Yasuoka R; Motoki K; Kobuke K; Iwanaga Y; Miyazaki S
    J Cardiol; 2015 Aug; 66(2):161-7. PubMed ID: 25468767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of increased OT dispersion in the 12-lead standard ECG for arrhythmia risk prediction in dilated cardiomyopathy.
    Grimm W; Steder U; Menz V; Hoffmann J; Grote F; Maisch B
    Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1886-9. PubMed ID: 8945062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate variability and dispersion of QT interval in patients with vulnerability to ventricular tachycardia and ventricular fibrillation after previous myocardial infarction.
    Perkiömäki JS; Huikuri HV; Koistinen JM; Mäkikallio T; Castellanos A; Myerburg RJ
    J Am Coll Cardiol; 1997 Nov; 30(5):1331-8. PubMed ID: 9350936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone reduces QT dispersion in patients with hypertrophic cardiomyopathy.
    Dritsas A; Gilligan D; Nihoyannopoulos P; Oakley CM
    Int J Cardiol; 1992 Sep; 36(3):345-9. PubMed ID: 1428268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tpeak-Tend interval during therapeutic hypothermia can predict upcoming ventricular fibrillation in subjects with aborted arrhythmic sudden cardiac death: 3-years follow-up results.
    Yoon N; Hong S; Glass A; Kim SS; Kim MC; Cho JY; Lee KH; Sim DS; Yoon HJ; Kim KH; Hong YJ; Park HW; Kim JH; Ahn Y; Jeong M; Park JC; Cho JG
    Europace; 2017 Dec; 19(suppl_4):iv17-iv24. PubMed ID: 29220423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT dispersion and early arrhythmic risk during acute myocardial infarction.
    Paventi S; Bevilacqua U; Parafati MA; Di Luzio E; Rossi F; Pelliccioni PR
    Angiology; 1999 Mar; 50(3):209-15. PubMed ID: 10088800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
    Konecná P; Dvorák R; Semrád B
    Vnitr Lek; 1999 Aug; 45(8):453-6. PubMed ID: 11045143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT dispersion significantly increases after implantable cardioverter-defibrillator shocks.
    Topaloglu S; Aras D; Sahin O; Ergun K; Deveci B; Ozdemir O; Ozeke O; Yildiz A; Alyan O; Demir AD; Soylu M; Kisacik HL; Korkmaz S
    Ann Noninvasive Electrocardiol; 2007 Jan; 12(1):44-9. PubMed ID: 17286650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iohexol contrast medium induces QT prolongation in amiodarone patients.
    Goernig M; Kirmeier T; Krack A; Hartog CS; Figulla HR; Leder U
    Br J Clin Pharmacol; 2004 Jul; 58(1):96-8. PubMed ID: 15206999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
    Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M
    J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in myocardial infarction survivors with left ventricular dysfunction is predicted by electrocardiographic RR interval but not QT dispersion.
    Pedretti RF; Catalano O; Ballardini L; de Bono DP; Radice E; Tramarin R
    Int J Cardiol; 1999 Jan; 68(1):83-93. PubMed ID: 10077405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia.
    Boriani G; Biffi M; De Simone N; Bacchi L; Martignani C; Bitonti F; Zannoli R; Butrous G; Branzi A
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1935-8. PubMed ID: 11139961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Iacoviello M; Forleo C; Guida P; Romito R; Sorgente A; Sorrentino S; Catucci S; Mastropasqua F; Pitzalis M
    J Am Coll Cardiol; 2007 Jul; 50(3):225-31. PubMed ID: 17631214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of change of signal-averaged electrocardiogram identifies patients with ventricular arrhythmias who are non-responders to amiodarone.
    Brembilla-Perrot B; Claudon O; Houriez P; Beurrier D; Suty-Selton C
    Int J Cardiol; 2002 Apr; 83(1):47-55. PubMed ID: 11959384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.